Iain B. McInnes

机构：Arthritis UK, Institute of Infection and Immunity, Adam Smith Institute, University of Glasgow · ORCID：0000-0002-6462-4280

发表论文 1326 篇 · 总被引 106041 次 · h-index 142

代表论文

• Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial (2025 · Nature Medicine · 被引 17)
• Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial (2026 · The Lancet Rheumatology · 被引 11)
• Academia Europaea’s guidelines for the visualization of clinical outcomes (2025 · Nature Medicine · 被引 11)
• Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis (2026 · Nature Reviews Rheumatology · 被引 7)
• OP0004 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY (2025 · Annals of the Rheumatic Diseases · 被引 5)
• Spatial profiling of giant cell arteritis tissues reveals immune heterogeneity and potential predictors of glucocorticoid response (2025 · Annals of the Rheumatic Diseases · 被引 3)